Intuitive Surgical, Inc. $ISRG Shares Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 229,842 shares of the medical equipment provider’s stock after purchasing an additional 15,879 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Intuitive Surgical were worth $124,898,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in ISRG. Brighton Jones LLC boosted its stake in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. NBC Securities Inc. purchased a new position in shares of Intuitive Surgical in the first quarter valued at $135,000. Merit Financial Group LLC boosted its stake in shares of Intuitive Surgical by 17.2% in the first quarter. Merit Financial Group LLC now owns 7,811 shares of the medical equipment provider’s stock valued at $3,869,000 after purchasing an additional 1,147 shares during the period. ST Germain D J Co. Inc. boosted its stake in shares of Intuitive Surgical by 69.8% in the first quarter. ST Germain D J Co. Inc. now owns 73 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 30 shares during the period. Finally, HBW Advisory Services LLC boosted its stake in shares of Intuitive Surgical by 11.1% in the first quarter. HBW Advisory Services LLC now owns 542 shares of the medical equipment provider’s stock valued at $268,000 after purchasing an additional 54 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on ISRG shares. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Royal Bank Of Canada reiterated an “outperform” rating and set a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Evercore ISI increased their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a research note on Tuesday, July 8th. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Finally, Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Fourteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $594.19.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $443.01 on Friday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company’s fifty day moving average is $464.42 and its two-hundred day moving average is $500.22. The stock has a market capitalization of $158.81 billion, a price-to-earnings ratio of 61.79, a price-to-earnings-growth ratio of 4.59 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same period last year, the firm posted $1.78 EPS. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director directly owned 739 shares in the company, valued at $325,669.91. This trade represents a 31.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 in the last ninety days. 0.70% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.